格隆汇3月19日｜美光科技(MU.O)批准将季度股息提高30%。

Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong interest from investigators and patients; topline data expected in H1 2027 PRISM wet AMD Phase 2b 2-year data expected in mid-2026 and SPECTRA DME trial 2-year data in H2 2026 4D-150 DME global Phase 3 trial initiation expected in Q3 2026 $514 million in cash, cash equivalents and marketable securities expected to fund current operating plan into second half of 2028 EMERYVILLE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today reported full year 2025 financial results, provided operational highlights and outlined expected upcoming milestones. “2025 was a transformative year for 4DMT highlighted by meaningful progress advancing 4D-150 with rapid Phase 3 trial enrollment, presenting strong 4D-150 Phase 1/2 durability data, entering a strategic partnership with Otsuka and strengthening our financial position,” said David Kirn, M.D., Co-founder, President and Chief Executive Officer of 4DMT. “These achievements position us well for execution in 2026 and beyond as we continue toward our goal of redefining the treatment paradigm for retinal vascular disease with 4D-150, with our first pivotal data readout for wet AMD expected in the first half of 2027.” Recent Corporate Highlights Expanded Leadership to Support Late-Stage Execution and Commercial Readiness Glenn P. Sblendorio joined the 4DMT Board of Directors and will serve on the Compensation and Science & Technology committees Kristian Humer joined as Chief Financial Officer Julie Clark, M.D., was promoted to Chief Medical Officer Katy Barglow, Ph.D., was promoted to Chief Technical Officer Kim Maplestone was promoted to Chief C...

DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2025 financial results after market close on Wednesday, March 25, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date/Time: Wednesday, March 25, 2026, at 4:30 p.m. ET / 2:30 p.m. MT Webcast: The live webcast and replay can be found here. Register for the call: Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration. A replay of the call will be available after 7:30 p.m. ET and can be accessed here. About SeaStar Medical SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. SeaStar Medical’s first commercial product, QUELIMMUNE (SCD-PED) , was approved in 2024 by the U.S. Food and Drug Administration (FDA). It is the only FDA approved product for the ultra-rare condition of life-threatening Acute Kidney Injury (AKI) due to sepsis or a septic condition requiring renal replacement therapy (RRT) in critically ill pediatric patients. SeaStar Medical’s Selective Cytopheretic Device (SCD) therapy has been awarded Breakthrough Device Designation for six therapeutic indications by the FDA, enabling the potential for a speedier pathway to approval and preferable reimbursement dynamics at commercial launch. The company is currently conducting the NEUTRALIZE-AKI pivotal clinical trial of its SCD therapy in adult patients with AKI requiring continuous renal replacement therapy, a life-threatening condition with no effective treatment options that impacts over 200,000 adults in the U.S. annually. For more information visit...

CAMBRIDGE, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, and provide a business update on Thursday, March 26, 2026, after market close. The Company does not intend to host a conference call. About Spero Therapeutics Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need. For more information, visit www.sperotherapeutics.com. Investor Relations Contact: Shai Biran, PhD Spero Therapeutics IR@Sperotherapeutics.com Media Inquiries: media@sperotherapeutics.com

SALT LAKE CITY, March 18, 2026 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, reports its financial results for the year ended December 31, 2025.

4DMT fills pivotal eye-disease trial early, setting up 2027 readout Stock Titan

da-kuk/E+ via Getty Images The market is still making the same analytical mistake with AI infrastructure: it keeps trying to force every “AI cloud” company into a single category. That instinct is understandable because the software market trained investors to look for one eventual winning model, one dominant interface, one best platform, one clean margin structure. But AI cloud does not appear to be developing that way. It is not converging toward a unified model. It is splitting into at least two distinct businesses. One business is built around control. The other is built around convenience The control business sells bare-metal access, Kubernetes-level orchestration, reserved GPU capacity, and direct exposure to the newest systems with as little abstraction as possible. The customer in that market is not looking for a prettier interface or a more opinionated cloud wrapper. It is usually a hyperscaler, a frontier lab, a sovereign actor, or a very sophisticated enterprise buyer with its own infrastructure teams and its own preferences for how workloads should be run. What these customers want is not cloud experience. They want keys to the machine. The convenience business is something different. It is software-abstracted infrastructure designed for customers who do not want to manage the entire stack themselves. Here, the provider creates value by making deployment easier, reducing operational friction, adding security and governance, simplifying billing, and wrapping raw infrastructure in tools that make it accessible to enterprises and smaller builders. This part of the market looks more familiar because it resembles cloud and SaaS logic. Customers are buying time-to-use and risk reduction rather than maximum control. That distinction matters because these are not merely two maturity stages of the same product. They may be two separate profit pools with different buyers, different moats, and different valuation frameworks. The market still tends to interpret them...

Micron Technology Inc. , the largest US maker of computer memory chips, offered a positive forecast for the current quarter after surging prices for the components bolstered its prospects. Fiscal third-quarter revenue will be approximately $33.5 billion, the company said in a statement Wednesday. Analysts estimated $23.7 billion on average for the period. Excluding some items, profit will be about $19.15 a share, compared with a projection of $11.29. Memory prices are soaring because of shortages fueled by AI computing demand. So-called high-bandwidth memory is critical to the data transfer in the workhorse chips for training and running AI models. That’s led memory makers to allocate more production to these higher-margin orders, hurting supply of other types of memory and causing price spikes. Read More: Why the AI Boom Will Make Phones, Cars, Devices More Expensive Micron gained about 1% in late trading after the results were released Wednesday. The shares had risen 62% this year heading into the report, making it the best-performing stock on the closely watched Philadelphia Stock Exchange Semiconductor Index. For the fiscal second quarter, which ended Feb. 26, sales nearly tripled to $23.9 billion. Earnings climbed to $12.20 a share. Analysts had estimated $19.7 billion in revenue and $9 a share in profit on average, according to data compiled by Bloomberg. The company and other memory-chip makers have benefited from an unprecedented data center build-out. Their market is dominated by just three providers — Micron, Samsung Electronics Co. and SK Hynix Inc. — and demand is expected to stay strong for years to come. Memory shortages have been good for Micron and its peers, but hard on the broader tech industry and consumers. Supply constraints have raised prices and lowered the number of smartphones and computers slated to ship this year. HP Inc. said last month that the company has seen memory prices roughly double in the current quarter from the previous period....

Key Points Prediction markets have started to see the odds of recession increasing this year. Investors would be smart to stick to a strategy focused on dollar-cost averaging into a core ETF holding. 10 stocks we like better than Vanguard S&P 500 ETF › Given the ongoing conflict in the Middle East, the odds of a U.S. recession have been rising on prediction market platforms like Kalshi and Polymarket. Odds are currently hovering around 30%, although they have topped 35% on both platforms at times this month. The question is whether investors should take heed and prepare for a potential recession. From a purely economic standpoint, the war and the blocking of the Strait of Hormuz by Iran could lead to higher prices at the pump, which is very likely to impact the U.S. consumer, who has already been struggling with high inflation stemming from tariffs. Meanwhile, the closure could lead to supply disruptions in other industries as well, as diverting ships to the Cape of Good Hope adds transport days and increases costs. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » As such, the longer this conflict lasts, the greater the potential threat of a recession this year. However, while the 30% odds of a recession are relatively high, the odds suggest the market is still leaning toward there not being a recession this year. There is so much spending on artificial intelligence (AI) infrastructure right now that it is driving tremendous growth. Meanwhile, AI is also helping make companies more efficient, allowing them to automate tasks and improve productivity. The combination of heavy capital investment and rising productivity should help support corporate earnings even as recession risks rise. What should investors do? At this point, I think investors should stick to their strategy for the most part. If you ...

Micron Gives Upbeat Forecast After Demand Soars for Memory Chips Bloomberg.com

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Google is increasing its use of Chinese suppliers for advanced liquid cooling systems that support its data center and AI infrastructure. The shift is linked to component supply pressures in Taiwan and reflects a change in how Alphabet sources key hardware for AI workloads. This development creates new supply chain dependencies that may carry geopolitical and regulatory considerations for NasdaqGS:GOOGL. Alphabet, trading as NasdaqGS:GOOGL, is leaning further into Chinese liquid cooling providers as it scales out AI focused data centers. With the share price at $310.92 and a 1 year return of 94.2%, the company is already in focus for many investors who follow large US technology names closely. This new sourcing pattern may influence how you think about Alphabet's exposure to cross border trade rules, export controls and regional tensions. It also provides another perspective on how the company is building out AI capacity in response to heavier compute loads and tighter supply of critical components in Taiwan. Stay updated on the most important news stories for Alphabet by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Alphabet. NasdaqGS:GOOGL Earnings & Revenue Growth as at Mar 2026 We've flagged 1 risk for Alphabet. See which could impact your investment. Quick Assessment ✅ Price vs Analyst Target : At US$310.92, Alphabet trades about 17% below the US$376.75 analyst price target. ⚖️ Simply Wall St Valuation : Shares are described as trading close to estimated fair value. ✅ Recent Momentum: The 30 day return of roughly 1.7% points to mildly positive near term momentum. There is only one way to know the right time to buy, sell or hold Alphabet. Head to Simply Wall St's company report for the latest analysis of Alphabet's Fair Value. Key Considerations 📊 Greater reliance on Chinese liquid cooling su...

格隆汇3月19日｜美光科技(MU.O)预计第三季度调整后毛利率约为81%，此前预期为72.4%。

Repurposing Old AMD APUs For AI Work Hackaday

The BC250 is what AMD calls an APU, or Accelerated Processing Unit. It combines a GPU and CPU into a single unit, and was originally built to serve as the heart of certain Samsung rack mount servers. If you know where to find cheap surplus units of the BC250, you can put them to good use for AI work, as [akandr] demonstrates. The first thing you’ll have to figure out is how to take an individual BC250 APU and get it up and running. It’s effectively a full system-on-chip, combining a Zen 2 CPU with a Cyan Skillfish RDNA 1.5 GPU. However, it was originally intended to run inside a rackmount server unit rather than a standalone machine. To get it going, you’ll need to hook it up with power and some kind of cooling solution. From there, it’s a matter of software. [akandr] explains how to get AI workflows running on the BC250 using Ollama and Vulkan, while noting useful hacks to improve performance like disabling the GUI and tweaking the CPU governor. The hardware can be used with a wide range of different models depending on what you’re trying to achieve, it just takes some careful management of the APU’s resources to get the most out of it. Thankfully, that’s all in the guide on GitHub. We’ve already seen these AMD APUs repurposed before for gaming use. Unfortunately the word is out already about their capabilities, so prices have risen significantly in response to demand. Still, if you manage to score a BC250 and do something cool with it yourself, be sure to let us know on the tipsline!

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. OpenAI is reportedly in talks with Amazon on a potential $50b arrangement that could give Amazon access to OpenAI models on its cloud. Microsoft is considering legal action to block the deal in order to protect its existing exclusive AI and Azure cloud partnership with OpenAI. The dispute could reshape competitive dynamics across enterprise AI and hyperscaler infrastructure providers. For investors following Microsoft, ticker NasdaqGS:MSFT, this possible break in exclusivity comes at a time when the stock trades around $399.41 per share. The company has delivered a 49.3% return over the past 3 years and 75.2% over 5 years, which helps explain why its AI positioning and cloud partnerships are closely watched. If Microsoft’s access to OpenAI models becomes less exclusive, factors such as the terms, technical integration, and timing could all influence how attractive Azure remains to large AI customers. The outcome of any legal challenge, together with any renegotiated partnership structures, will likely shape how investors evaluate Microsoft’s competitive moat in enterprise AI and its role among the major hyperscalers. Stay updated on the most important news stories for Microsoft by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Microsoft. NasdaqGS:MSFT 1-Year Stock Price Chart Is Microsoft's balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis. Quick Assessment ✅ Price vs Analyst Target : At US$399.41, Microsoft trades about 33% below the US$594.62 analyst target. ✅ Simply Wall St Valuation : Shares are described as trading 10.5% below estimated fair value. ❌ Recent Momentum: The 30 day return of about 0.48% decline shows short term weakness. There is only one way to know the right time to buy, sell or hold Microsoft. Head to Simply Wall ...

(MU) Micron Technology, Inc. Expects Q3 Revenue Range $32.75B - $34.25B marketscreener.com

Micron beats quarterly revenue estimates marketscreener.com

This Key Metric Says That Nvidia (NVDA) Is Now a ‘Value Stock’ TipRanks

(MU) Micron Technology, Inc. Expects Q3 Adjusted EPS Range $18.75 - $19.55 marketscreener.com

Five Below press release ( FIVE ): Q4 Non-GAAP EPS of $4.31 beats by $0.31 . Revenue of $1.73B (+24.5% Y/Y) beats by $20M . For the first quarter of Fiscal 2026: Net sales are expected to be in the range of $1.18 billion to $1.20 billion based on opening approximately 45 net new stores and assumes an approximate 14% to 16% increase in comparable sales. Net income is expected to be in the range of $86 million to $93 million. Adjusted net income (3) is expected to be in the range of $88 million to $94 million. Diluted income per common share is expected to be in the range of $1.55 to $1.67 on approximately 55.6 million diluted weighted average shares outstanding. Adjusted diluted income per common share (3) is expected to be in the range of $1.57 to $1.69. For the full year of Fiscal 2026: Net sales are expected to be in the range of $5.20 billion to $5.30 billion based on opening approximately 150 net new stores and assumes an approximate 3% to 5% increase in comparable sales. Net income is expected to be in the range of $429 million to $457 million. Adjusted net income (4) is expected to be in the range of $431 million to $459 million. Diluted income per common share is expected to be in the range of $7.69 to $8.20 on approximately 55.7 million diluted weighted average shares outstanding. Adjusted diluted income per common share (4) is expected to be in the range of $7.74 to $8.25. Gross capital expenditures are expected to be approximately $230 million to $250 million in fiscal 2026. More on Five Below Five Below: A Top Performing Retailer Trading At Highs, Shares Fairly Valued Five Below, Inc. (FIVE) Presents at ICR Conference 2026 Transcript Five Below's On-Trend Merchandise May Now Be Priced In Five Below Q4 2026 Earnings Preview Retail rundown: Dollar Tree and Five Below could benefit from new tariff structure

Two and a half hours into one of the most unforgettable battles of his career, Jack Draper resolved to attack without hesitation, regardless of the outcome. On two pivotal points in his Indian Wells fourth-round match against Novak Djokovic, at 4-4 in the tie-break and then on match point at 6-6, Draper forced himself inside the baseline and unleashed two backhands, those shots driving him to victory. It would have been understandable for Draper to have played passive tennis in those decisive moments. Not only did Indian Wells mark his second ATP tournament back after sustaining a bone bruise to his left arm that forced him off the tour for seven months, the injury has forced him to make dramatic changes to his game. Draper returns to the circuit using natural gut strings in a hybrid string setup. Until this year, the 24-year-old had spent his career playing with synthetic polyester strings in his mains and crosses, respectively the vertical and horizontal strings within his racket’s string bed, but Draper and his team decided that it was appropriate for him to switch to natural gut in his mains. Natural gut strings are made from cow intestines and for a large part of the 20th century they were the only viable string option for elite players. However, the modernisation of professional tennis has been driven by the introduction of poly strings. While natural gut strings are much softer and more elastic, allowing players more power and feel, the firmer poly strings have helped modern players to consistently hit with greater spin and control while swinging freely from all parts of the court. At 6ft 4in, Draper generates significant power and his spinny forehand is one of the heaviest in the game. These changes plainly do not suit his playing style. However, the elasticity of the strings make them far friendlier to the arm and body. Considering he has a history of left-arm injuries, he decided this was the way forward. View image in fullscreen Jack Draper and Novak Djok...

格隆汇3月19日｜美光科技(MU.O)预期第三季度营收327.5亿美元至342.5亿美元，市场预期为243亿美元。

格隆汇3月19日｜美光科技(MU.O)美股盘后涨2%。

Something unusual is happening: The Federal Reserve is now more likely to raise rates by this summer than it is to cut them. The Atlanta Fed's Market Probability Tracker now shows the odds of a rate hike stand at 19.2%, while the chances of a rate cut sit at 17.3%. This is a sharp reversal from where these probabilities stood in late February — before the U.S.-Iran war began. In Feb. 27, the likelihood of an interest rate cut stood at 39.7%, while offs of a rate hike were single digits, the tracker showed. "A month ago, no one would have believed this," Ryan Detrick, chief market strategist at Carson Group, wrote in an X post on Tuesday. Detrick told CNBC on Wednesday that "the war and the spike in commodities across the board has pushed the rate hike percentages higher. At the same time, we've been seeing inflation concerns even before the war started." Oil prices have spiked higher since the war began, raising concern among some economists about stagflation . This takes place when an economy is marked by high inflation and weak growth. Data released Wednesday added to those fears. The producer price index , which measures a broad basket of wholesale prices, rose in February by 0.7%. PPI also rose 3.4% on an annual basis. Inflationary pressures compounded with a weak job market and rising oil prices could push the Fed to hike interest rates. The Fed last raised interest rates in its July 2023 meeting, with the hopes of slowing inflation down in the aftermath of Covid. The FOMC cut interest rates three times by 25 basis points each in 2025, and the year ended with interest rates in the range of 3.5%-3.75%. The Fed opted to keep rates steady in January as well as on Wednesday, with some comments raising worries about inflation. "In the near term, higher energy prices will push up overall inflation, but it is too soon to know the scope and duration of the potential effects on the economy," Chair Jerome Powell said in a news briefing Wednesday. "We are balancing these ...

Earnings Flash (MU) Micron Technology, Inc. Reports Q2 Revenue $23.86B, vs. FactSet Est of $19.97B marketscreener.com

格隆汇3月19日｜CFRA公司股票市场策略师Sam Stovall表示，我认为美联储所传达的信息是，他们对油价对通胀的推升作用更为担忧，但同时又告诉我们他们相信经济依然稳定且坚实。他们的看法似乎是，通胀状况在短期内有可能自行得到解决，从而不会对经济造成不利影响：它可能会只是一个减速的障碍，而非一座不可逾越的壁垒。

Envela press release ( ELA ): Q4 GAAP EPS of $0.23 beats by $0.14 . Revenue of $80.49M (+66.6% Y/Y) beats by $28.24M . Full year 2025 operating expenses were $35.8 million, compared to $36.2 million in 2024. Fourth quarter operating expenses were $9.0 million, compared to $9.3 million in the prior-year quarter. Full year 2025 operating income was $18.1 million, compared to $8.2 million in 2024. Fourth quarter operating income was $7.5 million, compared to $1.9 million in the prior-year quarter. Full year 2025 Adjusted EBITDA was $20.0 million, or 8.3% of revenue, compared to $9.7 million, or 5.4% of revenue in 2024. Fourth quarter Adjusted EBITDA was $8.0 million, or 3.3% of revenue, compared to $2.3 million, or 4.8% of revenue in the prior-year quarter. Full year 2025 Adjusted EBITDAR was $22.5 million, or 9.4% of revenue, compared to $11.8 million, or 6.6% of revenue in 2024. Fourth quarter Adjusted EBITDAR was $8.7 million, or 3.6% of revenue, compared to $2.9 million, or 1.6% of revenue in the prior-year quarter. More on Envela Envela: Record Gold Prices Could Drive New Highs Seeking Alpha’s Quant Rating on Envela Historical earnings data for Envela Financial information for Envela

Micron Technology press release ( MU ): Q2 Non-GAAP EPS of $12.20 beats by $3.54 . Revenue of $23.86B (+196.4% Y/Y) beats by $4.56B . On March 18, 2026, Micron’s Board of Directors declared a quarterly dividend of $0.15 per share, payable in cash on April 15, 2026, to shareholders of record as of the close of business on March 30, 2026. The following table presents Micron’s guidance for the third quarter of 2026: FQ3-26 GAAP (1) Outlook Non-GAAP (2) Outlook Revenue $33.5 billion ± $750 million vs consensus of $23.27B $33.5 billion ± $750 million Gross margin Approximately 81% Approximately 81% Operating expenses Approximately $1.60 billion Approximately $1.40 billion Diluted earnings per share $18.90 ± $0.40 $19.15 ± $0.40vs consensus of $10.77 Click to enlarge Shares +2.33% AH. More on Micron Technology Micron's Stock May Plunge Following Earnings Results Micron: The 4-To-1 New Catalyst Earnings Preview: We'll See How Much Upside Micron Has Intel tops forward P/E list at 91x as Micron prepares to report amid AI demand surge AI, chip stocks mixed ahead of Micron's earnings

格隆汇3月19日｜Angeles投资公司首席投资官Michael Rosen表示，美联储的声明与市场预期基本一致，并未改变我们的投资看法。从总体上看，美联储的态度略显强硬，此次会议中仅有一人反对维持利率不变（米兰的观点），而上次会议中有两个反对意见。前瞻性预期（即“点阵图”）也与预期相符，只是未来长期利率有所小幅上调。今年和明年预计会降息一次。